Lacosamide
NDC 59651-016, Lacosamide, solution, from Aurobindo Pharma Limited.
- Product NDC
- 59651-016
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209224
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/59651-016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-016-02 | 59651001602 | 200 mL in 1 BOTTLE, PLASTIC (59651-016-02) |
| 59651-016-46 | 59651001646 | 465 mL in 1 BOTTLE, PLASTIC (59651-016-46) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/614490ce-a62c-4222-8e4b-ce802cf63028NADAC price for package 59651001602
GET /v1/drugs/nadac/59651001602
Use it
Look up 59651-016 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-016 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.